Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica · Delayed Price · Currency is JMD 2.640
0.00 (0.00%)
At close: Sep 28, 2026
Indies Pharma Jamaica Ratios and Metrics
Market cap in millions JMD. Fiscal year is November - October.
Millions JMD. Fiscal year is Nov - Oct.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| 3,518 | 3,784 | 4,224 | 4,184 | 4,184 | 4,531 | |
Market Cap Growth | -14.29% | -10.41% | 0.95% | 0% | -7.65% | 25.93% |
Enterprise Value | 4,315 | 4,412 | 4,904 | 4,839 | 4,918 | 5,265 |
Last Close Price | 2.64 | 2.71 | 2.90 | 2.76 | 2.66 | 2.78 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
PE Ratio | 26.42 | 20.88 | 19.10 | 19.64 | 18.95 | 26.99 |
PS Ratio | 3.12 | 3.36 | 3.65 | 3.96 | 4.46 | 5.35 |
PB Ratio | 2.01 | 2.19 | 3.27 | 3.43 | 3.62 | 4.17 |
P/TBV Ratio | 2.86 | 3.06 | 5.08 | 5.38 | 5.38 | 5.89 |
P/FCF Ratio | 10.55 | 11.82 | 17.52 | 15.76 | 14.49 | 13.91 |
P/OCF Ratio | 9.23 | 10.40 | 16.90 | 14.97 | 13.27 | 12.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
EV/Sales Ratio | 3.83 | 3.92 | 4.23 | 4.59 | 5.25 | 6.22 |
EV/EBITDA Ratio | 14.27 | 15.32 | 16.17 | 16.74 | 16.34 | 22.55 |
EV/EBIT Ratio | 18.31 | 16.76 | 17.32 | 17.91 | 17.46 | 24.22 |
EV/FCF Ratio | 12.94 | 13.77 | 20.34 | 18.23 | 17.02 | 16.16 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Debt / Equity Ratio | 0.69 | 0.59 | 0.66 | 0.74 | 0.71 | 0.79 |
Debt / EBITDA Ratio | 4.02 | 3.08 | 2.48 | 2.73 | 2.41 | 3.15 |
Debt / FCF Ratio | 3.65 | 3.17 | 3.55 | 3.40 | 2.82 | 2.63 |
Net Debt / Equity Ratio | 0.45 | 0.34 | 0.49 | 0.53 | 0.50 | 0.61 |
Net Debt / EBITDA Ratio | 3.06 | 2.06 | 2.09 | 2.23 | 1.93 | 2.86 |
Net Debt / FCF Ratio | 2.39 | 1.85 | 2.63 | 2.43 | 2.01 | 2.05 |
Asset Turnover | 0.38 | 0.42 | 0.51 | 0.49 | 0.46 | 0.46 |
Inventory Turnover | 2.58 | 2.26 | 2.22 | 2.41 | 1.63 | 1.79 |
Quick Ratio | 3.69 | 2.91 | 0.45 | 2.92 | 5.70 | 3.19 |
Current Ratio | 4.57 | 4.98 | 0.85 | 5.07 | 10.24 | 5.84 |
Return on Equity (ROE) | 7.68% | 11.99% | 17.61% | 17.93% | 19.68% | 18.62% |
Return on Assets (ROA) | 4.97% | 6.14% | 7.78% | 7.88% | 8.62% | 7.30% |
Return on Invested Capital (ROIC) | 8.98% | 11.21% | 13.12% | 14.69% | 16.14% | 14.28% |
Return on Capital Employed (ROCE) | 8.00% | 9.20% | 20.60% | 12.90% | 14.20% | 11.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Earnings Yield | 3.79% | 4.79% | 5.24% | 5.09% | 5.28% | 3.71% |
FCF Yield | 9.48% | 8.46% | 5.71% | 6.34% | 6.90% | 7.19% |
Dividend Yield | 5.11% | 4.98% | 3.79% | 3.99% | 4.25% | 3.96% |
Payout Ratio | 134.94% | 99.23% | 66.27% | 70.86% | 68.20% | 87.32% |
Total Shareholder Return | 5.36% | 4.98% | 3.79% | 3.99% | 4.25% | 3.96% |